thioctic acid has been researched along with Thyroid Neoplasms in 2 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
Excerpt | Relevance | Reference |
---|---|---|
"ALA suppressed thyroid cancer cell proliferation through activation of AMPK and subsequent down-regulation of mammalian target of rapamycin (mTOR)-S6 signaling pathway." | 1.43 | Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells. ( Choi, HJ; Jeon, MJ; Kim, TY; Kim, WB; Kim, WG; Lim, S; Shong, YK; Sim, S, 2016) |
"Patients with metastatic thyroid cancers that do not uptake iodine need effective therapeutic option." | 1.38 | Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line. ( Choi, HJ; Han, JM; Jeon, MJ; Kim, TY; Kim, WB; Kim, WG; Ruiz-Llorente, S; Shong, YK, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeon, MJ | 2 |
Kim, WG | 2 |
Lim, S | 1 |
Choi, HJ | 2 |
Sim, S | 1 |
Kim, TY | 2 |
Shong, YK | 2 |
Kim, WB | 2 |
Ruiz-Llorente, S | 1 |
Han, JM | 1 |
2 other studies available for thioctic acid and Thyroid Neoplasms
Article | Year |
---|---|
Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell | 2016 |
Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
Topics: Antioxidants; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Drug Synerg | 2012 |